newsmaker

Attention Investors: Time’s Running Out! Faruqi & Faruqi LLP Digs into Kyverna Therapeutics for You

Welcome to the World of Securities Litigation: A Look into Kyverna Therapeutics, Inc. The Story of Kyverna Therapeutics, Inc. Let’s dive into the intriguing world of securities litigation with a focus on Kyverna Therapeutics, Inc. If you’re an investor who suffered losses exceeding $50,000 in Kyverna common stock, you may want to pay close attention….

Read More

Clever and Personable: Marvel Biosciences Announces Private Placement for Up to $2.5 Million

Marvel Biosciences Corp. Announces Non-Brokered Private Placement CALGARY, ALBERTA–(Newsfile Corp. – January 7, 2025) Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) (“Marvel” or the “Company”) has revealed plans to carry out a non-brokered private placement of common shares of the Company at a rate of $0.15 per Common Share, with anticipated gross proceeds ranging from…

Read More

Breaking News: Marpai Secures Up to $5 Million in Non-Dilutive Growth Funding from JGB!

Marpai, Inc. Secures Additional $5,000,000 Funding for Growth Initiatives TAMPA, Fla., Jan. 6, 2025 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded…

Read More

Join the Fight: Deadline Approaching for XRX Class Action Suit – Contact Levi Korsinsky Now!

Seeking Recovery for Xerox Holdings Corporation Investment Losses Introduction With the constantly changing stock market and investment landscape, it’s not uncommon for investors to experience losses on their investments. If you find yourself in this situation with Xerox Holdings Corporation (NASDAQ:XRX), there may be a potential opportunity for recovery under the federal securities laws. It’s…

Read More

Attention Investors: Don’t Miss Out on Your Chance to Seek Justice with Applied Therapeutics Inc. (APLT) – Act Now!

Important Deadline for Applied Therapeutics Investors Are you an investor who purchased Applied Therapeutics, Inc. (APLT) securities between January 3, 2024 and December 2, 2024? Act Now to Protect Your Rights Attention all investors! The Law Offices of Howard G. Smith is reminding you of an upcoming deadline to file a lead plaintiff motion in…

Read More